Hangzhou Minsheng Healthcare Valuation

Is 301507 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 301507 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 301507 (CN¥13.45) is trading above our estimate of fair value (CN¥8.31)

Significantly Below Fair Value: 301507 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 301507?

Key metric: As 301507 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 301507. This is calculated by dividing 301507's market cap by their current earnings.
What is 301507's PE Ratio?
PE Ratio	53.2x
Earnings	CN¥90.14m
Market Cap	CN¥4.80b

301507 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	6.4x
Enterprise Value/EBITDA	42.3x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 301507's PE Ratio compare to its peers?

The above table shows the PE ratio for 301507 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	22.9x
001328 Dencare (Chongqing) Oral Care	34.1x	17.4%	CN¥5.2b
603896 Zhejiang Shouxiangu Pharmaceutical	18.7x	19.4%	CN¥4.4b
605009 Hangzhou Haoyue Personal Care	14.5x	16.4%	CN¥6.1b
300740 SYoung Group	24.1x	23.7%	CN¥5.0b
301507 Hangzhou Minsheng Healthcare	53.2x	n/a	CN¥4.8b

Price-To-Earnings vs Peers: 301507 is expensive based on its Price-To-Earnings Ratio (53.2x) compared to the peer average (22.9x).

Price to Earnings Ratio vs Industry

How does 301507's PE Ratio compare vs other companies in the CN Personal Products Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 301507 is expensive based on its Price-To-Earnings Ratio (53.2x) compared to the CN Personal Products industry average (33.9x).

Price to Earnings Ratio vs Fair Ratio

What is 301507's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

301507 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	53.2x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 301507's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

SYoung Group

CN¥5.0b

Engages in the research and development, production, and sale of cosmetic products in China.

300740

CN¥12.95

-6.8%

-21.8%

Byhealth

CN¥21.7b

Develops and sells dietary supplements.

300146

CN¥12.89

-5.0%

-29.8%

Sirio Pharma

CN¥6.4b

Operates as a contract manufacturer for dietary supplement industry worldwide.

300791

CN¥27.36

-3.5%

6.2%